On December 29, 2011 the Judicial Panel on Multidistrict Litigation (JPML) established MDL No. 2299 for all federal claims alleging injury caused by the diabetes drug Actos. Actos, manufactured by Takeda Pharmaceuticals America Inc., is the tenth best-selling medication in the U.S. and has been found to increase the risk of developing bladder cancer in patients who have taken Actos for more than one year. The MDL is assigned to Judge Rebecca F. Doherty of the U. S. District Court for the Western District of Louisiana. Showard Law Firm will be filing local claims directly in the MDL.
Author: Sarah Showardhttp://showardlaw.com
Sarah Showard graduated from the University of Maryland in 1985, Magna Cum Laude with a Bachelor of Arts in English-Linguistics and a Certification in Women's Studies. She then graduated from New York University School of Law in 1988. Sarah began practice initially as an insurance defense attorney, and has been representing plaintiffs since 1990.